Elderly patients with suspected Charcot-Marie-Tooth disease should be tested for the TTR gene for effective treatments

[1]  R. Lewis,et al.  European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision , 2021, European journal of neurology.

[2]  R. Lewis,et al.  European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision , 2021, Journal of the peripheral nervous system : JPNS.

[3]  T. Murohara,et al.  Multidisciplinary Approaches for Transthyretin Amyloidosis , 2021, Cardiology and Therapy.

[4]  S. Tsuji,et al.  Genetic spectrum of Charcot–Marie–Tooth disease associated with myelin protein zero gene variants in Japan , 2020, Clinical genetics.

[5]  W. Wiszniewski,et al.  Screening for genetic mutations in patients with neuropathy without definite etiology is useful , 2020, Journal of Neurology.

[6]  Paco Derouault,et al.  CovCopCan: An efficient tool to detect Copy Number Variation from amplicon sequencing data in inherited diseases and cancer , 2020, PLoS Comput. Biol..

[7]  P. Hawkins,et al.  Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy , 2020, Journal of Neurology.

[8]  Aslıhan Uzunkulaoğlu,et al.  Terminal Latency Index, Residual Latency, and Median-Ulnar F-Wave Latency Difference in Carpal Tunnel Syndrome , 2019, Annals of Indian Academy of Neurology.

[9]  A. Gracia Gutiérrez,et al.  Estimating the prevalence of allelic variants in the transthyretin gene by analysing large-scale sequencing data , 2019, European Journal of Human Genetics.

[10]  T. Yokochi,et al.  Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report , 2018, Journal of Medical Case Reports.

[11]  L. Santoro,et al.  Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy “in disguise” , 2018, Orphanet Journal of Rare Diseases.

[12]  M. Nakagawa,et al.  Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[13]  J. Sung,et al.  Characteristics of South Korean Patients with Hereditary Transthyretin Amyloidosis , 2018, Journal of clinical neurology.

[14]  S. Solomon,et al.  Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis , 2018, The New England journal of medicine.

[15]  D. Herrmann,et al.  Carpal tunnel syndrome in inherited neuropathies: A retrospective survey , 2018, Muscle & nerve.

[16]  L. Amass,et al.  Estimating the global prevalence of transthyretin familial amyloid polyneuropathy , 2018, Muscle & nerve.

[17]  Y. Ando,et al.  Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm , 2018, Orphanet Journal of Rare Diseases.

[18]  H. Feigenbaum,et al.  Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy , 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[19]  S. Tsuji,et al.  Clinical and genetic diversities of Charcot‐Marie‐Tooth disease with MFN2 mutations in a large case study , 2017, Journal of the peripheral nervous system : JPNS.

[20]  L. Amass,et al.  Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial , 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[21]  B. Vahdatpour,et al.  Comparative study of shock wave therapy and Laser therapy effect in elimination of symptoms among patients with myofascial pain syndrome in upper trapezius , 2016, Advanced biomedical research.

[22]  B. Vahdatpour,et al.  The role of median nerve terminal latency index in the diagnosis of carpal tunnel syndrome in comparison with other electrodiagnostic parameters , 2016, Advanced biomedical research.

[23]  S. Tsuji,et al.  Mutations in MME cause an autosomal‐recessive Charcot–Marie–Tooth disease type 2 , 2016, Annals of neurology.

[24]  B. Hazenberg,et al.  First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy , 2016, Current opinion in neurology.

[25]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[26]  Hee-Jin Kim,et al.  Asp58Ala is the Predominant Mutation of the TTR Gene in Korean Patients with Hereditary Transthyretin‐Related Amyloidosis , 2015, Annals of human genetics.

[27]  Tomonori Nakamura,et al.  Neurofilament light mutation causes hereditary motor and sensory neuropathy with pyramidal signs , 2014, Journal of the peripheral nervous system : JPNS.

[28]  H. Takashima,et al.  A family with distal hereditary motor neuropathy and a K141Q mutation of small heat shock protein HSPB1. , 2014, Internal medicine.

[29]  Yukio Ando,et al.  Guideline of transthyretin-related hereditary amyloidosis for clinicians , 2013, Orphanet Journal of Rare Diseases.

[30]  G. Sobue,et al.  Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  J. Vallat,et al.  Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy , 2012, Muscle & nerve.

[32]  C. Briani,et al.  Variable presentations of TTR‐related familial amyloid polyneuropathy in seventeen patients , 2011, Journal of the peripheral nervous system : JPNS.

[33]  G. Sobue,et al.  Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis , 2011, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[34]  K. Ono,et al.  Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus , 2008, Journal of the Neurological Sciences.

[35]  B. Kim,et al.  Subclinical diabetic neuropathy with normal conventional electrophysiological study , 2007, Journal of Neurology.

[36]  Masaaki Nakamura,et al.  Transthyretin-related familial amyloidotic polyneuropathy. , 2005, Archives of neurology.

[37]  G. Sobue,et al.  Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[38]  J. Koyama,et al.  Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[39]  G. Sobue,et al.  Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. , 2003, Brain : a journal of neurology.

[40]  G. Sobue,et al.  Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form. , 2002, Archives of neurology.

[41]  G. Sobue,et al.  Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. , 2002, Neurology.

[42]  S. Yamaguchi,et al.  Transthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy , 2002, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[43]  S. Ikeda,et al.  Postmortem findings in two familial amyloidosis patients with transthyretin variant Asp38Ala , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[44]  D. Simovic,et al.  The median nerve terminal latency index in carpal tunnel syndrome: A clinical case selection study , 1999, Muscle & nerve.

[45]  Yoshiya Tanaka,et al.  Radiolabelled meta-iodobenzylguanidine in assessment of autonomic dysfunction , 1994, The Lancet.

[46]  Y. Yamamura,et al.  Studies on familial amyloid polyneuropathy in Ogawa Village, Japan. , 1980, European neurology.

[47]  P K Thomas,et al.  The clinical features of hereditary motor and sensory neuropathy types I and II. , 1980, Brain : a journal of neurology.

[48]  M. Ohta,et al.  Polyneuritic amyloidosis in a Japanese family. , 1968, Archives of neurology.

[49]  C ANDRADE,et al.  A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. , 1952, Brain : a journal of neurology.